Purdue Pharma, the embattled maker of the drug OxyContin, finds itself close to settling some of the thousands of lawsuits filed against it for the company's role in fueling the ongoing opioid epidemic.

The settlement forces the Sackler family to give up control of the Stamford, Connecticut-based business, according to the Associated Press, while the company will pay up to $12 billion over time.

Arizona Attorney General Mark Brnovic stated that the deal was the fastest way to help communities hit hard by the crisis while also increasing the payout initially offered by the defendant.

The pharmaceutical giant had been facing lawsuits from thousands of state, local, and Native American tribal governments. About 2,000 governments have agreed to the tentative deal, but about half of the states have not signed on.

"The families who were hurt by Purdue and the Sacklers have spoken loud and clear that this case demands real accountability, and I will continue to fight for that," Massachusetts Attorney General Maura Healey, who did not agree to the terms, wrote in a statement according to WBUR. “It’s critical that all the facts come out about what this company and its executives and directors did, that they apologize for the harm they caused, and that no one profits from breaking the law."

New Jersey Attorney General Gurbir Grewal also refrained from endorsing the settlement saying on Twitter, “New Jersey will continue to pursue all available legal options against those responsible. And if Purdue cannot pay for the harm it inflicted, the Sacklers will.”

The potential settlement comes two weeks after Johnson & Johnson was ordered to pay Oklahoma $572 million for its part in spreading addictive painkillers, a landmark first court decision during the opioid crisis that still fell short of the $17.2 billion the state was pursuing.

In March, Purdue and the Sacklers settled with the Sooner State for $272 million to pay for treatment, addiction research, and the state's legal fees.

According to data from the National Center for Health Statistics more than 47,000 people died from an opioid overdose in the U.S. in 2018.

Share:
More In Business
Federal Reserve: Inflation Is, Uh, Still Up
An inflation gauge favored by the Federal Reserve increased in January, the latest sign that the slowdown in U.S. consumer price increases is occurring unevenly from month to month. (Getty Images)
Is 2024 the Most Affordable Year to Buy a New Car?
After years of price increases for cars and trucks in the United States, costs are slowing and in some cases falling, helping cool overall inflation and giving frustrated Americans more hope of finding an affordable vehicle.
Missed Out on Nvidia? Consider These 5 Chip Stocks Instead
Missed out on the Nvidia wave? Oh course you did — you’re reading this article aren’t you, instead of luxuriating on a white-sand beaches of Bali. But here are at least four other promising semiconductor stocks to add to your portfolio.
Building Lapse, a New Social Media App
Fresh off a successful funding round, co-founder of Lapse Dan Silvertown shares thoughts on regulation, privacy, and why the money for great startups is still out there.
Load More